trazodone has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 3 studies
Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "She was found to have seizure activity without cerebral edema." | 1.51 | Arrhythmias in Severe Trazodone Overdose. ( Lee, MY; Soe, KK, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ryan, K | 1 |
| Benz, P | 1 |
| Zosel, A | 1 |
| Farkas, A | 1 |
| Theobald, J | 1 |
| Soe, KK | 1 |
| Lee, MY | 1 |
| Mazur, A | 1 |
| Strasberg, B | 1 |
| Kusniec, J | 1 |
| Sclarovsky, S | 1 |
3 other studies available for trazodone and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
QTc Prolongation in Poison Center Exposures to CredibleMeds List of Substances with "Known Risk of Torsades de Pointes".
Topics: Amitriptyline; Arrhythmias, Cardiac; Diphenhydramine; Electrocardiography; Flecainide; Humans; Long | 2022 |
Arrhythmias in Severe Trazodone Overdose.
Topics: Anti-Anxiety Agents; Anticonvulsants; Bundle-Branch Block; Dopamine; Drug Overdose; Electrocardiogra | 2019 |
QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Drug Interaction | 1995 |